Critical Materials Group Raises $10.3M Seed Round to Modernize U.S. Energetics Manufacturing
The investment comes as demand for domestic munitions and advanced energetics production reaches a critical inflection point. Decades of consolidation have left
"The
The Seed funding will also allow CMG to meet current commitments across its contract portfolio and move faster on facility commissioning as demand from
"CMG sits at the intersection of geopolitics and deep tech. Energetics, like rare earth minerals, sit upstream of nearly every
Founded in 2025, CMG has moved quickly to establish technical credibility and government alignment in a sector defined by long procurement cycles and high barriers to entry. The company's founding team brings experience from military service, defense contracting, and procurement, positioning itself as a trusted partner capable of filling the arsenal gaps the modern threat environment demands.
About Critical Materials Group (CMG):
Founded in 2025, Critical Materials Group, Inc. (CMG) is a privately held, Texas-based manufacturing company modernizing energetics production facilities critical to national security. CMG delivers modular, automation-ready production platforms and integrated techniques that embed safety into every stage of the manufacturing process, enabling resilient, scalable, and responsible domestic energetics production. Led by industry experts from laboratory and operational backgrounds, CMG is committed to safely and responsibly enabling lethality at scale to support allied defense readiness.
Media Contact:
[email protected]
View original content:https://www.prnewswire.com/news-releases/critical-materials-group-raises-10-3m-seed-round-to-modernize-us-energetics-manufacturing-302867026.html
SOURCE Critical Materials Group
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Munters completes expansion of data center cooling campus in Daleville, Virginia
- The U.S. FDA grants orphan drug designation for Lundbeck's investigational anti-ACTH monoclonal antibody asedebart for treatment of endogenous Cushing's syndrome
- Penetron Strengthens Sales and Technical Support in the Western USA
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share